ASXL1 and leukemia: In conclusion, this meta-analysis revealed that ASXL1 mutation had a significant adverse effect on the prognosis of PMF patients, and PMF patients with ASXL1 mutations had a shorter OS and a greater possibility of transformation to leukemia.